If there is going to be a buyout in a couple months, or even a couple quarters ... this does not seem likely to be able to add to any buyout price. But after a year or so, they might have done a few animal pre-clinicals. This should convey the broad uses for Pro140, and thus enter into the .... calculus (?) of a buyout price. I do not guess we are near the endgame.